Financial statements Spectro - Lab
Balance sheet data of SPECTRO - LAB
Year
|
2021
|
2022
|
2023
|
---|---|---|---|
Total assets | 32 865 975,74 | 38 874 016,76 | 74 808 636,59 |
A. Fixed assets | 11 063 822,99 | 11 251 817,48 | 11 528 069,24 |
B. Current assets | 21 802 152,75 | 27 622 199,28 | 63 280 567,35 |
C. Share capital contributions (basic funds) | - | - | - |
D. Own shares (stocks) | - | - | - |
Total liabilities | 32 865 975,74 | 38 874 016,76 | 74 808 636,59 |
A. Equity | 26 841 044,14 | 32 286 958,25 | 49 461 507,45 |
B. Liabilities and provisions for liabilities | 6 024 931,60 | 6 587 058,51 | 25 347 129,14 |
I. Long-term liabilities | 153 750,00 | 0,00 | 0,00 |
II. Short-term liabilities | 5 789 691,60 | 6 581 609,51 | 25 336 577,14 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.